Market Cap for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported market cap is $35.42B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingMarket CapSwitch metric
Latest period
$35.42B
YoY change
-18.0%
5Y CAGR
-2.9%
Peak year (2025)
$38.01B
Latest annual
$31.16B
Market Cap history chart for ResMed (RMD) from 1995 to 2026
Market Cap history table for ResMed (RMD) from 1995 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $31.16B | -18.0% | ||
| 2025 | $38.01B | +34.6% | ||
| 2024 | $28.24B | -12.3% | ||
| 2023 | $32.22B | +4.5% | ||
| 2022 | $30.82B | -14.6% | ||
| 2021 | $36.10B | +29.1% | ||
| 2020 | $27.97B | +58.6% | ||
| 2019 | $17.63B | +18.2% | ||
| 2018 | $14.91B | +34.4% | ||
| 2017 | $11.09B | +23.8% | ||
| 2016 | $8.96B | +11.4% | ||
| 2015 | $8.04B | +10.0% | ||
| 2014 | $7.31B | +10.6% | ||
| 2013 | $6.61B | +41.8% | ||
| 2012 | $4.66B | -4.2% | ||
| 2011 | $4.87B | +3.2% | ||
| 2010 | $4.72B | +50.2% | ||
| 2009 | $3.14B | +11.6% | ||
| 2008 | $2.81B | -12.9% | ||
| 2007 | $3.23B | -10.9% | ||
| 2006 | $3.62B | +46.5% | ||
| 2005 | $2.47B | +38.2% | ||
| 2004 | $1.79B | +32.6% | ||
| 2003 | $1.35B | +34.7% | ||
| 2002 | $1.00B | -40.8% | ||
| 2001 | $1.69B | +95.8% | ||
| 2000 | $864.43M | +67.6% | ||
| 1999 | $515.73M | +50.4% | ||
| 1998 | $342.81M | +92.7% | ||
| 1997 | $177.94M | +63.3% | ||
| 1996 | $108.98M | +107.6% | ||
| 1995 | $52.50M | — |
Market Cap values are taken from ResMed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
ResMed (RMD) most recent annual market cap stands at $31.16B (2026) – declined 18.0% year-over-year.
Over 2021–2026 (5 years), ResMed market cap expanded at a -2.9% compound annual rate, with a net decline across the window.
ResMed market cap peaked at $38.01B in 2025; the latest annual figure is $31.16B in 2026 (18.0% below peak).
The dataset's maximum market cap sits at $38.01B (2025); the minimum reading of $52.50M dates to 1995.
Among 8 Healthcare peers, ResMed (RMD) ranks 9th; the peer median for market cap is $311.16B.
ResMed Market Cap by Year
ResMed Market Cap 2026: $31.16B
ResMed market cap in 2026 was $31.16B, declined 18.0% below 2025.
ResMed Market Cap 2025: $38.01B
ResMed market cap in 2025 was $38.01B, surged 34.6% from 2024. This figure represents the highest annual value in the available history.
ResMed Market Cap 2024: $28.24B
ResMed market cap in 2024 was $28.24B, declined 12.3% below 2023.
ResMed Market Cap 2023: $32.22B
ResMed market cap in 2023 was $32.22B, edged up 4.5% from 2022.
ResMed Market Cap 2022: $30.82B
ResMed market cap in 2022 was $30.82B.
See more financial history for ResMed (RMD).
Sector peers — Market Cap
Companies in the same sector as ResMed, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is ResMed's market cap?
- Latest reported market cap for ResMed (RMD) is $35.42B (period ending December 31, 2025).
How has ResMed market cap changed year-over-year?
- ResMed (RMD) market cap changed -18.0% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed market cap?
- ResMed (RMD) market cap compound annual growth rate is -2.9% over the most recent 5 years available.
When did ResMed market cap hit its highest annual value?
- ResMed market cap reached its highest annual value of $38.01B in 2025.
What was ResMed market cap in 2025?
- ResMed (RMD) market cap in 2025 was $38.01B.
What was ResMed market cap in 2026?
- ResMed (RMD) market cap in 2026 was $31.16B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.